Regadenoson .08 mg/mL (Regadenoson INJECTION, SOLUTION) .08 mg/mL

Regadenoson .08 mg/mL is an injectable solution used for specific medical imaging procedures. This pharmaceutical, manufactured by Hospira, Inc., is designed to enhance diagnostic accuracy in certain cardiovascular assessments.

Strength

.08 mg/mL

Pack Size

10 CARTON in 1 PACKAGE (0409-1401-01) / 1 SYRINGE, PLASTIC in 1 CARTON / 5 mL in 1 SYRINGE, PLASTIC

Manufacturer / TM Owner

Hospira, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Regadenoson .08 mg/mL is primarily used as a pharmacological stress agent in myocardial perfusion imaging (MPI). This process helps healthcare professionals evaluate blood flow to the heart muscle. The solution is administered intravenously to simulate the effects of physical exercise, aiding in the detection of coronary artery disease. Regadenoson .08 mg/mL is often utilized when patients are unable to undergo physical stress testing.

Side Effects

Common effects of Regadenoson .08 mg/mL may include flushing, headache, chest discomfort, and shortness of breath. These effects are typically mild and transient, resolving shortly after administration. Patients may also experience dizziness or nausea. It is important to monitor patients closely during and after the procedure to ensure their safety and comfort.

Precautions & Warnings

Regadenoson .08 mg/mL should be used with caution in patients with asthma, low blood pressure, or a history of seizures. It is essential to inform healthcare providers about any allergies or medical conditions before administration. The solution should be stored at room temperature and protected from light. Always follow the manufacturer's guidelines for handling and disposal.

Avoid Interactions

Regadenoson .08 mg/mL may interact with certain medications, including those that affect heart rate or blood pressure. Patients should avoid caffeine and other stimulants before the procedure, as they can interfere with the accuracy of the imaging results. Always consult a healthcare provider for personalized advice regarding potential drug interactions.

Frequently Asked Questions

Regadenoson .08 mg/mL is used as a pharmacological stress agent in myocardial perfusion imaging to evaluate blood flow to the heart muscle.

Regadenoson .08 mg/mL is administered intravenously by a healthcare professional during a medical imaging procedure.

Common effects may include flushing, headache, chest discomfort, and shortness of breath, which are typically mild and transient.

Regadenoson .08 mg/mL may interact with certain medications, so it is important to consult a healthcare provider for personalized advice.

Regadenoson .08 mg/mL should be stored at room temperature and protected from light, following the manufacturer's guidelines.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.